Clinical Trial Update: Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AC-150 for allergic conjunctivitis completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• AC-150

Snippet

Sponsor: Aciex Therapeutics, Inc. | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2017-09-14